title: Ð Ð°Ð·ÑÐ°Ð±Ð¾ÑÐºÐ° ÑÑÑÐ°ÑÐµÐ³Ð¸Ð¸ Ð²ÑÑ Ð¾Ð´Ð° Ð±Ð¸Ð¾ÑÐµÑ Ð½Ð¾Ð»Ð¾Ð³Ð¸ÑÐµÑÐºÐ¾Ð³Ð¾ ÑÑÐ°ÑÑÐ°Ð¿Ð° Ð½Ð° ÑÑÐ½Ð¾Ðº ÐÐ¡
title: Ð²ÑÐ¿ÑÑÐºÐ½Ð°Ñ ÐºÐ²Ð°Ð»Ð¸ÑÐ¸ÐºÐ°ÑÐ¸Ð¾Ð½Ð½Ð°Ñ ÑÐ°Ð±Ð¾ÑÐ° Ð¼Ð°Ð³Ð¸ÑÑÑÐ°
titleType: Subtitle
title: Developing an EU market entry strategy for a biotech startup
Creators: name: ÐÑÑÐµÐ½Ñ, Ð¢Ð°ÑÑÑÐ½Ð°
Publisher: name: Ð¡Ð°Ð½ÐºÑ-ÐÐµÑÐµÑÐ±ÑÑÐ³ÑÐºÐ¸Ð¹ Ð¿Ð¾Ð»Ð¸ÑÐµÑÐ½Ð¸ÑÐµÑÐºÐ¸Ð¹ ÑÐ½Ð¸Ð²ÐµÑÑÐ¸ÑÐµÑ ÐÐµÑÑÐ° ÐÐµÐ»Ð¸ÐºÐ¾Ð³Ð¾
Year: 2021
Subjects: ÐÐ¸Ð¾ÑÐµÑ Ð½Ð¾Ð»Ð¾Ð³Ð¸Ñ
Ð´Ð¾ÑÐ¾Ð¶Ð½ÑÐµ ÐºÐ°ÑÑÑ
Ð°Ð´ÑÐµÑÐ½Ð°Ñ Ð´Ð¾ÑÑÐ°Ð²ÐºÐ°
ÑÑÑÐ°ÑÐµÐ³Ð¸Ñ Ð²ÑÑ Ð¾Ð´Ð° Ð½Ð° ÑÑÐ½Ð¾Ðº
ÐµÐ²ÑÐ¾Ð¿ÐµÐ¹ÑÐºÐ¸Ð¹ ÑÐ¾ÑÐ·
ÑÐµÐ³ÑÐ»Ð¸ÑÐ¾Ð²Ð°Ð½Ð¸Ðµ
Ð±Ð¸Ð·Ð½ÐµÑ-Ð¼Ð¾Ð´ÐµÐ»Ð¸
Ð¸Ð½ÑÐµÑÐ½Ð°ÑÐ¸Ð¾Ð½Ð°Ð»Ð¸Ð·Ð°ÑÐ¸Ñ
road maps
target drug delivery
market entry strategy
european union
regulation
business models
internationalisation

description: Ð Ð¿Ð¾ÑÐ»ÐµÐ´Ð½Ð¸Ðµ Ð³Ð¾Ð´Ñ ÑÐ°Ð·Ð²Ð¸ÑÐ¸Ðµ Ð±Ð¸Ð¾ÑÐµÑÐ½Ð¾Ð»Ð¾Ð³Ð¸Ð¹, ÑÐ¿Ð¾ÑÐ¾Ð±ÑÑÐ²ÑÑÑÐ¸Ñ ÑÐ»ÑÑÑÐµÐ½Ð¸Ñ Ð·Ð´Ð¾ÑÐ¾Ð²ÑÑ ÑÐµÐ»Ð¾Ð²ÐµÐºÐ°, Ð°ÐºÑÐ¸Ð²Ð½Ð¾ Ð¿ÑÐ¾Ð´Ð²Ð¸Ð³Ð°ÐµÑÑÑ Ð¿Ð¾ Ð²ÑÐµÐ¼Ñ Ð¼Ð¸ÑÑ. Ð¡ÑÐ°ÑÑÐ°Ð¿ AETech LLC Ð·Ð°Ð½Ð¸Ð¼Ð°ÐµÑÑÑ ÑÐ°Ð·ÑÐ°Ð±Ð¾ÑÐºÐ¾Ð¹ Ð½Ð¾Ð²ÑÑ ÑÐµÑÐ½Ð¾Ð»Ð¾Ð³Ð¸Ð¹ Ð² Ð¾Ð±Ð»Ð°ÑÑÐ¸ Ð±Ð¸Ð¾ÑÐµÑÐ½Ð¾Ð»Ð¾Ð³Ð¸Ð¹. ÐÑÐ¾Ð´ÑÐºÑÐ¾Ð¼ ÐºÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ð¸ ÑÐ²Ð»ÑÐµÑÑÑ Ð¿ÑÐ¾ÑÐ¸Ð»Ð°ÐºÑÐ¸ÑÐµÑÐºÐ¾Ðµ ÑÑÐµÐ´ÑÑÐ²Ð¾ ÑÐ°Ð·Ð²Ð¸ÑÐ¸Ñ Ð·Ð°Ð±Ð¾Ð»ÐµÐ²Ð°Ð½Ð¸Ð¹ Ð¿Ð°ÑÐ¾Ð´Ð¾Ð½ÑÐ°, Ð¿Ð°ÑÐ¾Ð´Ð¾Ð½ÑÐ° Ð¸ ÑÐ»Ð¸Ð·Ð¸ÑÑÐ¾Ð¹ Ð¾Ð±Ð¾Ð»Ð¾ÑÐºÐ¸ Ð¿Ð¾Ð»Ð¾ÑÑÐ¸ ÑÑÐ°. ÐÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ñ Ð¿Ð»Ð°Ð½Ð¸ÑÑÐµÑ Ð¿ÑÐ¾Ð¸Ð·Ð²Ð¾Ð´ÑÑÐ²Ð¾ ÑÐ¾Ð»ÑÐºÐ¾ Ð·Ð° Ð¿ÑÐµÐ´ÐµÐ»Ð°Ð¼Ð¸ ÑÑÐ½ÐºÐ° Ð Ð¤. Ð¢Ð°ÐºÐ¸Ð¼ Ð¾Ð±ÑÐ°Ð·Ð¾Ð¼, ÑÐµÐ»ÑÑ Ð´Ð°Ð½Ð½Ð¾Ð³Ð¾ Ð¸ÑÑÐ»ÐµÐ´Ð¾Ð²Ð°Ð½Ð¸Ñ ÑÐ²Ð»ÑÐµÑÑÑ ÑÐ°Ð·ÑÐ°Ð±Ð¾ÑÐºÐ° ÐºÐ¾Ð¼Ð¿Ð»ÐµÐºÑÐ° ÑÐµÐºÐ¾Ð¼ÐµÐ½Ð´Ð°ÑÐ¸Ð¹ Ð¿Ð¾ Ð²ÑÐ²Ð¾Ð´Ñ Ð±Ð¸Ð¾ÑÐµÑÐ½Ð¾Ð»Ð¾Ð³Ð¸ÑÐµÑÐºÐ¾Ð³Ð¾ ÑÑÐ°ÑÑÐ°Ð¿Ð° AETech LLC Ð½Ð° ÑÑÐ½Ð¾Ðº ÑÑÑÐ°Ð½ ÐÐ²ÑÐ¾ÑÐ¾ÑÐ·Ð° Ñ ÑÑÐµÑÐ¾Ð¼ Ð¾ÑÑÑÑÑÑÐ²Ð¸Ñ Ð¾Ð¿ÑÑÐ° ÑÐ°Ð±Ð¾ÑÑ AETech LLC Ð½Ð° ÑÑÐ¾Ð¼ ÑÑÐ½ÐºÐµ. Ð ÑÐ½Ð¾Ðº Ð±Ð¸Ð¾ÑÐµÑÐ½Ð¾Ð»Ð¾Ð³Ð¸Ð¹ Ð°ÐºÑÐ¸Ð²Ð½Ð¾ ÑÐ°Ð·Ð²Ð¸Ð²Ð°ÐµÑÑÑ Ð² ÐÐ²ÑÐ¾Ð¿ÐµÐ¹ÑÐºÐ¾Ð¼ ÑÐ¾ÑÐ·Ðµ, Ð¾Ð´Ð½Ð°ÐºÐ¾ Ð¿Ð¾Ð´ÑÐ¾Ð±Ð½ÑÐµ Ð¸ÑÑÐ»ÐµÐ´Ð¾Ð²Ð°Ð½Ð¸Ñ Ð² Ð¾Ð±Ð»Ð°ÑÑÐ¸ Ð¸Ð½ÑÐµÑÐ½Ð°ÑÐ¸Ð¾Ð½Ð°Ð»Ð¸Ð·Ð°ÑÐ¸Ð¸ Ð±Ð¸Ð¾ÑÐµÑÐ½Ð¾Ð»Ð¾Ð³Ð¸ÑÐµÑÐºÐ¸Ñ ÑÑÐ°ÑÑÐ°Ð¿Ð¾Ð² Ð² ÑÐ²Ð¾Ð±Ð¾Ð´Ð½Ð¾Ð¼ Ð´Ð¾ÑÑÑÐ¿Ðµ Ð¾ÑÑÑÑÑÑÐ²ÑÑÑ. ÐÐ¾ÑÑÐ¾Ð¼Ñ Ð±ÑÐ»Ð¾ ÑÐµÑÐµÐ½Ð¾ ÑÐ°Ð·ÑÐ°Ð±Ð¾ÑÐ°ÑÑ Ð¾Ð¿Ð¸ÑÐ°ÑÐµÐ»ÑÐ½Ð¾Ðµ Ð¸ÑÑÐ»ÐµÐ´Ð¾Ð²Ð°Ð½Ð¸Ðµ, ÑÐ¾Ð±Ð¸ÑÐ°ÑÑÐµÐµ Ð´Ð°Ð½Ð½ÑÐµ Ð¸Ð· ÑÐ°Ð·Ð»Ð¸ÑÐ½ÑÑ Ð¸ÑÑÐ¾ÑÐ½Ð¸ÐºÐ¾Ð² Ð½Ð° Ð¿Ð¾Ð»Ð¸ÑÐ¸ÑÐµÑÐºÐ¸Ñ, ÑÐºÐ¾Ð½Ð¾Ð¼Ð¸ÑÐµÑÐºÐ¸Ñ Ð¸ Ð´ÑÑÐ³Ð¸Ñ ÑÑÐ¾Ð²Ð½ÑÑ, ÑÑÐ¾Ð±Ñ Ð¸Ð¼ÐµÑÑ Ð¿ÑÐµÐ´ÑÑÐ°Ð²Ð»ÐµÐ½Ð¸Ðµ Ð¾ ÑÑÐ½ÐºÐµ ÐÐ²ÑÐ¾ÑÐ¾ÑÐ·Ð° Ñ ÑÐ¾ÑÐºÐ¸ Ð·ÑÐµÐ½Ð¸Ñ ÐµÐ³Ð¾ Ð¿ÐµÑÑÐ¿ÐµÐºÑÐ¸Ð²Ð½Ð¾ÑÑÐ¸ Ð´Ð»Ñ Ð¸Ð½ÑÐµÑÐ½Ð°ÑÐ¸Ð¾Ð½Ð°Ð»Ð¸Ð·Ð°ÑÐ¸Ð¸ Ð±Ð¸Ð¾ÑÐµÑÐ½Ð¾Ð»Ð¾Ð³Ð¸ÑÐµÑÐºÐ¾Ð³Ð¾ ÑÑÐ°ÑÑÐ°Ð¿Ð° AETech LLC. ÐÐ¿Ð¾ÑÐ»ÐµÐ´ÑÑÐ²Ð¸Ð¸ Ð±ÑÐ»Ð¸ Ð¿ÑÐ¸Ð¼ÐµÐ½ÐµÐ½Ñ ÑÑÐ°ÑÐ¸ÑÑÐ¸ÑÐµÑÐºÐ¸Ðµ Ð¼ÐµÑÐ¾Ð´Ñ Ð´Ð»Ñ Ð¾ÑÐµÐ½ÐºÐ¸ ÑÐ¾Ð³Ð¾, Ð² ÐºÐ°ÐºÐ¸Ñ ÑÑÑÐ°Ð½Ð°Ñ ÑÑÐ°ÑÑÐ°Ð¿ AETech LLC Ð¼Ð¾Ð¶ÐµÑ Ð±ÑÑÑ Ð²Ð¾ÑÑÑÐµÐ±Ð¾Ð²Ð°Ð½, Ð° ÑÐ°ÐºÐ¶Ðµ ÑÐ°Ð·ÑÐ°Ð±Ð¾ÑÐ°Ð½ Ð½Ð°Ð±Ð¾Ñ ÑÐµÐºÐ¾Ð¼ÐµÐ½Ð´Ð°ÑÐ¸Ð¹ Ð´Ð»Ñ Ð¸Ð½ÑÐµÑÐ½Ð°ÑÐ¸Ð¾Ð½Ð°Ð»Ð¸Ð·Ð°ÑÐ¸Ð¸.
description: In recent years, the development of health-enhancing biotechnology has been promoted from various angles around the world. A start-up company AETech LLC is developing new technologies in the field of biotechnology. The company's product is a prophylactic agent for the development of periodontal, periodontal and oral mucosa diseases. The company plans to produce it only outside the Russian market. Thus, the purpose of this study is to develop a set of recommendations for the introduction of a biotech startup AETech LLC to the EU market, considering the lack of experience of AETech LLC in this market. The biotechnology market is actively developing in the European Union, but detailed studies on the internationalization of biotech start-ups are not freely available. Therefore, it was decided to develop a descriptive study collecting data from different sources on political, economic, social, and industrial levels in order to have an overview of the EU market in terms of its prospects for internationalization of a biotech start-up AETech LLC. Subsequently, statistical methods were applied to assess in which countries the AETech LLC startup could be in demand and a set of recommendations for its internationalization were developed.